# China NMPA Inspection - Shenzhen Neptunus Pharmaceutical Co., Ltd. - May 29, 2015

Source: https://www.globalkeysolutions.net/records/china_inspection/shenzhen-neptunus-pharmaceutical-co-ltd/3d7a15dc-b041-4aa0-a833-9e5cfed6107d/
Source feed: China

> China NMPA unannounced inspection for Shenzhen Neptunus Pharmaceutical Co., Ltd. published May 29, 2015. An unannounced inspection conducted by the State Food and Drug Administration and Guangdong Provincial Food and Drug Administration on May 21, 2015, b

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Surprise inspection findings of Shenzhen Neptunus Pharmaceutical Co., Ltd. and Ningbo Lihua Pharmaceutical Co., Ltd.
- Company Name: Shenzhen Neptunus Pharmaceutical Co., Ltd.
- Publication Date: 2015-05-29
- Product Type: Drugs
- Summary: An unannounced inspection conducted by the State Food and Drug Administration and Guangdong Provincial Food and Drug Administration on May 21, 2015, began at Shenzhen Haiwang Pharmaceutical Co., Ltd. This initial inspection revealed that Shenzhen Haiwang procured ginkgo leaf extract from Ningbo Lihua Pharmaceutical Co., Ltd. Consequently, an extended inspection was carried out at Ningbo Lihua from May 23 to 25, 2015. The investigation determined that Ningbo Lihua Pharmaceutical Co., Ltd. was suspected of purchasing ginkgo leaf extract from eight companies that lacked the necessary pharmaceutical production qualifications. These extracts were subsequently relabeled, and after passing internal quality control, were sold under Ningbo Lihua's name to various manufacturers. These included pharmaceutical companies like Shenzhen Haiwang Pharmaceutical Co., Ltd. and Yangtze River Pharmaceutical Group, which used the ingredients for Ginkgo biloba leaf medicines, and health food producers such as Wuxi Jiante Pharmaceutical Co., Ltd. In response, the Guangdong Provincial Food and Drug Administration has directed Shenzhen Haiwang Pharmaceutical Co., Ltd. to cease the production and sale of its Ginkgo biloba leaf preparations and has launched an investigation into the company. Concurrently, the Zhejiang Provincial Food and Drug Administration has initiated a thorough investigation into Ningbo Lihua Pharmaceutical Co., Ltd. regarding its alleged illicit sourcing and relabeling practices, underscoring the critical importance of maintaining strict adherence to regulatory standards for pharmaceutical ingredients.

Company: https://www.globalkeysolutions.net/companies/shenzhen-neptunus-pharmaceutical-co-ltd/c14c52c0-9330-45d0-9204-06d2c86e9cd3/